Biochem/physiol Actions
PDE3 catalyzes the phosphodiester bond hydrolysis, observed in secondory messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Inhibitors of PDE3 are generally inotropic and vasodilatory. They are being recognized for its use in treating heart failures. Cilostamide is known to delay meiotic progression.
Selective inhibitor of PDE3 (cGMP-inhibited phosphodiesterase); IC50 = 70 ± 9 nM. This inhibitory effect increases intracellular cAMP and inhibits platelet aggregation.
Molecular Weight: 342.43. Empirical Formula: C20H26N2O3. Quality Level: 100. Assay: ≥. 97% (HPLC). form: powder. solubility: DMSO: 20 . mg/mL, clear, colorless to faintly yellow. SMILES string: CN(C1CCCCC1)C(: O)CCCOc2ccc3NC(: O)C: Cc3c2. InChI: 1S/C20H26N2O3/c1-22(16-6-3-2-4-7-16)20(24)8-5-13-25-17-10-11-18-15(14-17)9-12-19(23)21-18/h9-12,14,16H,2-8,13H2,1H3,(H,21,23). InChI key: UIAYVIIHMORPSJ-UHFFFAOYSA-N. Gene Information: human ... PDE3A(5139), PDE3B(5140), PDE5A(8654), PDE7A(5150)rat ... Pde2a(81743), Pde4a(25638). Storage Class Code: 11 - Combustible Solids. WGK: WGK 3. Flash Point(F): Not applicable. Flash Point(C): Not applicable. Personal Protective Equipment: Eyeshields, Gloves, type N95 (US).
- UPC:
- 51171807
- Condition:
- New
- HazmatClass:
- No
- MPN:
- C7971-5MG
- CAS:
- 68550-75-4
akash.verma@cenmed.com
(732) 447-1115





